Difficulty: Medium
Average Score: 83%
Practice
Agents, which lower levels of LDL-cholesterol, tend to promote regression of atherosclerotic plaques. This consideration is:
Correct answer
A
Rationale
In pharmacology, agents that lower levels of LDL-cholesterol indeed tend to promote regression of atherosclerotic plaques. This is because LDL-cholesterol is a major contributor to the development and progression of atherosclerosis, a condition characterized by the buildup of plaques in the arteries. By reducing LDL-cholesterol levels, these agents help slow down or even reverse the accumulation of plaques, leading to regression of atherosclerosis.
Option A (TRUE) is correct because it aligns with the established pharmacological principles of managing atherosclerosis by targeting LDL-cholesterol levels. Lowering LDL-cholesterol is a key strategy in the treatment and prevention of atherosclerotic cardiovascular disease.
Options B, C, and D are incorrect because they do not acknowledge the relationship between LDL-cholesterol levels and atherosclerosis regression. Choosing any of these options would imply a misunderstanding of the pharmacological mechanisms involved in managing cardiovascular health.
From an educational perspective, understanding the role of LDL-cholesterol in atherosclerosis and the impact of pharmacological agents on plaque regression is crucial for healthcare professionals, especially those involved in cardiovascular care. This knowledge helps in making informed decisions about treatment strategies and optimizing patient outcomes in the management of cardiovascular diseases.
Option A (TRUE) is correct because it aligns with the established pharmacological principles of managing atherosclerosis by targeting LDL-cholesterol levels. Lowering LDL-cholesterol is a key strategy in the treatment and prevention of atherosclerotic cardiovascular disease.
Options B, C, and D are incorrect because they do not acknowledge the relationship between LDL-cholesterol levels and atherosclerosis regression. Choosing any of these options would imply a misunderstanding of the pharmacological mechanisms involved in managing cardiovascular health.
From an educational perspective, understanding the role of LDL-cholesterol in atherosclerosis and the impact of pharmacological agents on plaque regression is crucial for healthcare professionals, especially those involved in cardiovascular care. This knowledge helps in making informed decisions about treatment strategies and optimizing patient outcomes in the management of cardiovascular diseases.